8-K 1 j1622_8k.htm 8-K

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported)                May 27, 2003

 

Cephalon, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

 

0-19119

 

23-2484489

(State or Other Jurisdiction
of Incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

 

 

 

 

145 Brandywine Parkway
West Chester, Pennsylvania

 

 

 

19380

(Address of Principal Executive Offices)

 

 

 

(Zip Code)

 

 

 

 

 

Registrant’s telephone number, including area code             (610) 344-0200

 

 

 

 

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

ITEM 5.  OTHER EVENTS.

 

On May 27, 2003, Cephalon, Inc. (the “Registrant”), publicly announced the expiration of its bid to acquire Australia’s SIRTeX Medical Limited for A$4.85 per share.

 

The Registrant hereby incorporates by reference the press releases dated May 27, 2003 attached hereto as Exhibits 99.1 and 99.2, and made a part of this Item 5.

 

ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

 

(a)        Financial Statements of Business Acquired:   Not applicable

 

(b)        Pro Forma Financial Information:   Not applicable

 

(c)        Exhibits

 

 

Number

 

Description

 

99.1

 

Press Release – Cephalon, Inc. Announces Offer Period Expires on Cephalon’s Bid for SIRTeX Medical Limited (United States Press Release)

 

 

 

 

 

99.2

 

Press Release – Cephalon, Inc. Announces Offer Period Expires on Cephalon’s Bid for SIRTeX Medical Limited (Australian Press Release)

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

CEPHALON, INC.

 

 

 

 

Date:   May 29, 2003

By:

/s/ J. Kevin Buchi

 

 

 

J. Kevin Buchi

 

 

Senior Vice President and Chief Financial Officer

 

3

 

EXHIBIT INDEX

 

Exhibit
Number

 

Description

99.1

 

Press Release – Cephalon, Inc. Announces Offer Period Expires on Cephalon’s Bid for SIRTeX Medical Limited (United States Press Release)

 

 

 

99.2

 

Press Release – Cephalon, Inc. Announces Offer Period Expires on Cephalon’s Bid for SIRTeX Medical Limited (Australian Press Release)

 

4